Drug Profile
Zika and dengue combined vaccine - Excivion/Xenetic Biosciences
Latest Information Update: 28 Sep 2020
Price :
$50
*
At a glance
- Originator Excivion; Xenetic Biosciences
- Developer Xenetic Biosciences
- Class Dengue vaccines; Zika virus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Dengue; Zika virus infection
Most Recent Events
- 28 Sep 2020 No recent reports of development identified for research development in Dengue in United Kingdom (Parenteral)
- 28 Sep 2020 No recent reports of development identified for research development in Zika-virus-infection in United Kingdom (Parenteral)
- 18 Aug 2016 Xenetic Biosciences and Excivion collaborate to co-develop Zika and dengue vaccine in United Kingdom